Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum

Bryan Krastins,Amol Prakash,David A. Sarracino,Dobrin Nedelkov,Eric E. Niederkofler,Urban A. Kiernan,Randall W. Nelson,Maryann Vogelsang,Gouri Vadali,Alejandra Garces,Jennifer N. Sutton,Scott Peterman,Gregory Byram,Bruno Darbouret,Joëlle R. Pérusse,Nabil G. Seidah,Benoit Coulombe,Johan Gobom,Erik Portelius,Josef Pannee,Kaj Blennow,Vathany Kulasingam,Lewis Couchman,Caje Moniz,Mary F. Lopez

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum

2013

Objectives The aim of this study was to develop high-throughput, quantitative and highly selective mass spectrometric, targeted immunoassays for clinically important proteins in human plasma or serum.

Keywords:

Immunoassay
Blood proteins
Proteomics
Chromatography
Chemistry
Mass spectrometry
High-Throughput Screening Assays
highly selective
mass spectrometric
human plasma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations